The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Companion Diagnostic Market Research Report 2024
Synopsis
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global Companion Diagnostic market was valued at US$ 8820 million in 2023 and is anticipated to reach US$ 32340 million by 2030, witnessing a CAGR of 20.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic.
Report Scope
The Companion Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc
Segment by Type
Immunohistochemistry
Molecular Diagnosis
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Virology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.
The global Companion Diagnostic market was valued at US$ 8820 million in 2023 and is anticipated to reach US$ 32340 million by 2030, witnessing a CAGR of 20.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic.
Report Scope
The Companion Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc
Segment by Type
Immunohistochemistry
Molecular Diagnosis
Segment by Application
Oncology
Cardiovascular
Central Nervous System
Virology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnosis
1.3 Market by Application
1.3.1 Global Companion Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Virology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Market Perspective (2019-2030)
2.2 Companion Diagnostic Growth Trends by Region
2.2.1 Global Companion Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Companion Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Companion Diagnostic Market Dynamics
2.3.1 Companion Diagnostic Industry Trends
2.3.2 Companion Diagnostic Market Drivers
2.3.3 Companion Diagnostic Market Challenges
2.3.4 Companion Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Players by Revenue
3.1.1 Global Top Companion Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Revenue
3.4 Global Companion Diagnostic Market Concentration Ratio
3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2023
3.5 Companion Diagnostic Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Breakdown Data by Type
4.1 Global Companion Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Companion Diagnostic Forecasted Market Size by Type (2025-2030)
5 Companion Diagnostic Breakdown Data by Application
5.1 Global Companion Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Companion Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Diagnostic Market Size (2019-2030)
6.2 North America Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Diagnostic Market Size by Country (2019-2024)
6.4 North America Companion Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostic Market Size (2019-2030)
7.2 Europe Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Diagnostic Market Size by Country (2019-2024)
7.4 Europe Companion Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Market Size (2019-2030)
9.2 Latin America Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Companion Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Holdings
11.1.1 Roche Holdings Company Detail
11.1.2 Roche Holdings Business Overview
11.1.3 Roche Holdings Companion Diagnostic Introduction
11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2019-2024)
11.1.5 Roche Holdings Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Companion Diagnostic Introduction
11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Detail
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies Companion Diagnostic Introduction
11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2019-2024)
11.4.5 Agilent Technologies Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Companion Diagnostic Introduction
11.5.4 Merck Revenue in Companion Diagnostic Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Agendia
11.6.1 Agendia Company Detail
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Business (2019-2024)
11.6.5 Agendia Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Companion Diagnostic Introduction
11.7.4 Qiagen Revenue in Companion Diagnostic Business (2019-2024)
11.7.5 Qiagen Recent Development
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Detail
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Diagnostic Introduction
11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2019-2024)
11.8.5 Myriad Genetics Recent Development
11.9 Advanced Cell Diagnostics
11.9.1 Advanced Cell Diagnostics Company Detail
11.9.2 Advanced Cell Diagnostics Business Overview
11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2019-2024)
11.9.5 Advanced Cell Diagnostics Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Illumina, Inc
11.11.1 Illumina, Inc Company Detail
11.11.2 Illumina, Inc Business Overview
11.11.3 Illumina, Inc Companion Diagnostic Introduction
11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2019-2024)
11.11.5 Illumina, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
